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Transforming growth factor-1 increases glucocorticoid binding Both the intensity and the duration of inflammatory
and signaling in macrophages through a Smad- and activated processes are limited by the expression of anti-inflamma-
protein-1–mediated process. tory molecules. They include circulating hormones suchBackground. Renal inflammation is regulated by a network
as glucocorticoids, as well as mediators produced at theof local and systemic mediators. Of them, transforming growth
inflammatory site, including interleukin-(IL) 4, IL-6, IL-10,factor-1 (TGF-1) and glucocorticoids play an important role
in deactivating monocytes/macrophages. We examined the hy- and IL-13, somatostatin, and transforming growth factor-
pothesis that TGF-1 effects may be partially achieved through (TGF-) [1]. Glucocorticoids control inflammation by
modulation of the sensitivity of these cells to glucocorticoids.
decreasing the transcription of inflammatory genes andMethods. Human promonocytic U 937 cells differentiated to
increasing that of anti-inflammatory genes [2]. They ex-a mature macrophage-like phenotype were exposed to recombi-
nant TGF-1 before specific binding of [3H] dexamethasone was ert these effects through intracellular glucocorticoid re-
measured. The expression of glucocorticoid receptor (GR) was ceptors (GR) that regulate gene transcription in two
examined by RNase protection assay and Western blot analysis. different ways [3]. First, GR may form a homodimerThe role of Smad 2/3 and activator protein 1 (AP-1) in the
that binds glucocorticoid-responsive elements (GREs)response to TGF-1 was determined by introducing transdomi-
in the 5 upstream promoter or enhancer region of gluco-nant negative mutants and decoy oligodeoxynucleotides, re-
spectively. corticoid-responsive genes to increase or repress the rate
Results. U 937 cell exposure to TGF-1 caused a dose- and of transcription. Alternatively, GR monomer may inter-
time-dependent increase in [3H] dexamethasone binding to these
act directly with other transcription factors such as acti-cells, with a twofold increase in the number of binding sites
vator protein-1 (AP-1) and nuclear factor-B (NF-B)per cell, without modification of the affinity. The changes in
glucocorticoid binding were associated with identical changes to suppress their efficacy. Thus the availability of GR is
in GR protein and mRNA levels, that were explained by an a major factor limiting glucocorticoid efficiency [4].
increase in GR gene transcription rather than by posttranscrip- In inflammatory processes, factors that potentiallytional mechanisms. Functional inactivation of Smad 2/3 and
modulate GR availability are numerous, including gluco-AP-1 limited the response to TGF-1, indicating a role for these
corticoids themselves that may down-regulate GR concen-transcription factors. Finally, increases in glucocorticoid bind-
ing to GR were responsible for increases in the ability of GR tration [4]. Anti-inflammatory mediators may also modu-
to transactivate minimal promoters containing glucocorticoid- late the number and/or the affinity of GR [1]. Supporting
responsive elements (GRE) [MMTV-Luc and (GRE)2 TK-Luc]. this possibility, in vitro exposure of monocytes to IL-13Conclusion. TGF-1 increases glucocorticoid binding and
has been shown to induce an increase in GR numbersignaling in inflammatory cells through a Smad 2/3- and AP-1–
mediated process. This may represent a new target for interven- with a significant reduction in GR-binding affinity so that
tion to increase glucocorticoid responsiveness. glucocorticoid responsiveness would be limited [5]. In
contrast, pretreatment of these cells with IL-10 promotes
an increase in the number of glucocorticoid binding sites
1See Editorial by Steinmetz and Stahl, p. 2317.
without significant modification of their binding affinity
Key words: glucocorticoid, Smad, inflammation. [6]. As a consequence, the sensitivity of monocytes to gluco-
corticoids appears enhanced. Exposure of monocytes/
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a hormone-binding form rather than to the increased for one-point binding assays, a saturating concentration
expression of GR. of [3H] dexamethasone was used (32 nmol/L). Unlabeled
Anti-inflammatory mediators also include TGF- that dexamethasone was used at a concentration of 20 mol/L.
deactivates inflammatory cells by impairing their adhe- After incubation at 37C for 2 hours, monolayers were
siveness, by inhibiting the release of reactive oxygen in- washed six times with cold phosphate-buffered saline
termediates, reactive nitrogen intermediates and pro- (PBS), and cells were lysed in 1 N NaOH. Lysates were
inflammatory cytokines, and by counteracting the effects harvested and counted in a beta spectrometer.
of pro-inflammatory cytokines [8–10]. The molecular
RNase protection assay (RPA)mechanisms used by TGF- to elicit these effects involve
mainly the activation of Smad proteins that control gene To quantitate GR mRNA levels, Rnase protection
transcription directly or in cooperation with other tran- assay (RPA) was performed as described previously [7].
scription factors [11, 12]. Whether TGF-1, like other RNA was cohybridized with 32P-labeled probes for hu-
anti-inflammatory mediators, may modulate GR avail- man GR and cyclophilin. Human GR probe was synthe-
ability is still not known. Therefore, the present study sized by using a cDNA insert in PGEM7ZF plasmid
was undertaken to explore the effects of TGF-1 on gluco- linearized with ACC I enzyme (a generous gift from Dr.
corticoid binding. Evidence was obtained that TGF-1 Nicolette Farman, INSERM U 478, Paris, France). This
increases glucocorticoid binding and signaling in U 937 probe contains 399 nucleotides, of which 362 are pro-
cells differentiated to a mature macrophage-like pheno- tected by hybridization to the human GR mRNA (resi-
type. This regulation is mediated, at least in part, via dues 682 to1044). Human cyclophilin probe was synthe-
a Smad- and AP-1–dependent induction of GR gene sized by using a cDNA insert in pBluescript SK plasmid
transcription. linearized with NCO I enzyme (a generous gift from
Dr. Marc Lombes, INSERM U 478, Paris, France). This
probe contains 240 nucleotides, of which 187 are pro-METHODS
tected by hybridization to the human cyclophilin mRNACells
(residues 437 to 624). The results were normalized and
The promonocytic U 937 cell line was obtained from expressed as the GR mRNA/cyclophilin mRNA ratio
the American Type Culture Collection (ATCC, Rock- (arbitrary units).
ville, MD, USA) and maintained at 37C in a culture me-
dium [RPMI 1640 with 10 mmol/L N-2-hydroxyethylpiper- Western blotting
azine-N-2-ethanesulfonic acid (HEPES), 100 units/mL
Culture medium was removed and PMA-differenti-penicillin, and 100 g/mL streptomycin] supplemented
ated U 937 cells were resuspended in 1.5 mL of PBSwith 10% fetal calf serum (FCS), under a 5% CO2 95% using a cell scraper. The cells were then pelleted byair atmosphere. These cells were differentiated to a mature
centrifugation (600  g, 4C for 10 minutes), frozen atmacrophage-like phenotype, as previously described [13]:
	80C for 4 hours, thawed, and resuspended in 100 L0.5  106 cells per mL of culture medium supplemented
of ice-cold protease inhibitory buffer [1 mmol/L phenyl-with 2.5% FCS were pretreated for 24 hours with 1.2%
methylsulfonyl fluoride, 20 g/mL leupeptin, 20 g/mLdimethyl sulfoxide (DMSO), washed, and resuspended
aprotinin in 50 mmol/L Tris (pH 7.4), 100 mmol/L NaCl,in 0.5 mL per well of culture medium (24-well plate).
2 mmol/L ethylenediaminetetraacetic acid (EDTA), andThey were treated by phorbol 12-myristate 13-acetate
1% Nonidet P-40]. The lysate was centrifuged (4000  g,(PMA) (50 ng/mL; Sigma Chemical Co., St. Louis, MO,
4C for 30 minutes). A 10 L portion of the supernatantsUSA) for 3 hours at 37C, washed, and then incubated
was reserved for protein determination, and protein con-with the indicated concentrations of TGF-1 (human
centration in supernatant samples was adjusted with therecombinant, Sigma). Monocytes were obtained by plas-
protease inhibitory buffer. These samples were boiled fortic adherence of peripheral blood mononuclear cells from
3 minutes in Laemli loading buffer and subjected to elec-healthy volunteers, as previously described [14].
trophoresis on a 7.5% polyacrylamide-sodium dodecyl
Glucocorticoid receptor assay sulfate (SDS) gel. Proteins were electroeluted onto a
nitrocellulose membrane (Immobilon-P, Millipore, Bed-A whole cell binding assay was used to determine GR
ford, MA, USA) that was blocked for 18 hours at 4Cnumber and affinity in untreated and TGF-–treated
in 10% nonfat dry milk solution in PBS  0.1% Tween.cells [7]. PMA-differentiated U 937 cells were incubated
GR was detected using a polyclonal antibody (1:100 dilu-in culture medium supplemented with 2.5% FCS and
tion; Affinity Bioreagents, Golden, CO, USA) and acontaining [3H] dexamethasone (85.0 Ci/mmol) (Amer-
peroxidase-labeled anti-immunoglobulin G (IgG) sec-sham Pharmacia Biotech Europe, Saclay, France) to-
ondary antibody (1:20,000 dilution). Thereafter, the mem-gether with or without unlabeled dexamethasone (Sigma
brane was developed with the ECL detection reagentChemical Co.). For Scatchard analysis, the concentration
of [3H] dexamethasone ranged from 0.5 to 64 nmol/L; (Amersham Pharmacia Biotech).
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Plasmids and oligonucleotides RESULTS
TGF-1 increases glucocorticoid binding inThe ph GR-Luc construct containing the 	2738 to
19 human GR promoter fragment upstream of the PMA-differentiated U 937 cells
luciferase reporter gene was kindly provided by Dr. To assess the effects of TGF-1 on glucocorticoid
Wayne Vedeckis (Louisiana State University, New Or- binding in cells differentiated to a mature macrophage-
leans, LA, USA) [15]. Constructs encoding Smad 2 and like phenotype, U 937 cells were first differentiated in
Smad 3 with C-terminal truncation (Smad 2
c and Smad the presence of PMA and then exposed to varying con-
3
c, respectively) that act in a dominant-negative man- centrations of TGF-1 for 24 hours before binding exper-
ner [16] were kindly provided by Dr. Alain Mauviel iments with [3H] dexamethasone were performed. The
(INSERM U 532, Hoˆpital Saint-Louis, Paris, France). addition of TGF-1 augmented [3H] dexamethasone spe-
The MMTV-Luc construct containing the mouse mam- cific binding in a dose-dependent fashion (Fig. 1A). Max-
mary tumor virus long terminal repeat with four GRE imal effect was seen at a TGF-1 concentration of 10
sites [17] and the [GRE]2 TK-Luc, a glucocorticoid- ng/mL. For this concentration, increase in [3H] dexa-
inducible reporter plasmid containing a minimal pro- methasone specific binding appeared after 4 hours of
moter with two GRE sites [7], were kindly provided by exposure and peaked at 24 hours (Fig. 1B). To assess
Dr. M.-G. Catelli (CNRS UPR 1524, Paris, France). The further the effect of TGF-1 on glucocorticoid binding
control TK-Luc vector was purchased from Promega to monocytes/macrophages, a subset of experiments was
(Madison, WI, USA). The sequences of phosphorothio- repeated using isolated human monocytes. Exposure of
ate double-stranded oligodeoxynucleotides against AP-1 these cells to TGF-1 caused a dose-dependent increase
binding site and mismatched decoy oligodeoxynucleo- in [3H] dexamethasone specific binding comparable to
tides were as follows: AP-1 decoy (5-AGCTTGTGAG that observed in PMA-differentiated U 937 cells (Fig.
TCAGAAGCT-3 and 3-TCGAACACTCAGTCTT 1C).
CGA-5) and mismatched decoy (5-AGCTTGAATCT To determine whether TGF-1 promoted an increase
CAGAAGCT-3 and 3-TCGAACTTAGAGTCT-TC in GR number or affinity, saturation binding and Scatch-
GA-5) [18]. ard analysis were performed (Fig. 2). Exposure of PMA-
differentiated U 937 cells to 10 ng/mL TGF-1 for 18
Transient transfection and luciferase assay hours yielded a twofold increase in the average num-
Undifferentiated U 937 cells were transfected with ber of GR sites per cell (control cells 88,000  5300;
either construct using the DEAE-dextran procedure, TGF-1–treated cells 143,000  20,200; P  0.05; N  3)
and luciferase activity was assayed as described [7]. without significant modification of the kD value (control
cells 10.0  1.0 nmol/L; TGF-1–treated cells 11.5  3.0
Electrophoretic mobility shift assay (EMSA) nmol/L; not significant).
PMA-differentiated U 937 cells were incubated with
TGF-1 increases GR expression by up-regulating GRor without 10 ng/mL TGF-1 for 1 to 24 hours. Nuclear
gene transcriptionextracts were prepared and electrophoretic mobility shift
assay (EMSA) was performed as described [19] using To determine whether the above effects of TGF-1
the double-stranded AP-1 site probe 5-AGCTAGGT on glucocorticoid binding could be related to differences
GACTCACCAAGCT-3; 3-TCCACTGAGTGGTTC in amounts of GR, Western blotting of cell lysate protein
GAAGCT-5. was carried out (Fig. 3A). Treatment of PMA-differenti-
ated U 937 cells with TGF-1 for 18 hours caused a
Enzyme-linked immunosorbent assay (ELISA) for IL-8 dose-dependent increase in GR protein.
The cell supernatants were harvested after 24 hours, To elucidate further the mechanism responsible for
centrifuged to remove cell debris, and stored at –80C the changes in amounts of GR protein, the steady-state
until they were analyzed for IL-8. Concentrations of IL-8 levels of GR mRNA were determined by RPA (Fig. 3
were measured by enzyme-linked immunosorbent assay B and C). Treatment of PMA-differentiated U 937 cells
(ELISA) (Quantikine human IL-8, R&D Systems, Abing- with TGF-1 also enhanced levels of GR mRNA in a
don, UK). The minimum detection concentration was concentration-dependent manner. This could result from
10 pg/mL. an increase in GR gene transcription, GR mRNA stabil-
ity, or both. To determine the effect of TGF-1 on the
Statistics stability of GR mRNA, changes in GR mRNA levels
were determined after cell exposure to dichloro-1--d-Comparisons between groups of values were made
with the Student t test or the two-way analysis of variance ribofuranosylbenzimidazole (DRB), a specific RNA poly-
merase II inhibitor. As shown in Figure 4A, GR mRNA(ANOVA). A difference between groups of P  0.05
was considered significant. exhibited a similar decay curve both in untreated cells
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Fig. 1. Effect of transforming growth factor-1
(TGF-1) on [3H] dexamethasone specific
binding. (A) Phorbol 12-myristate 13-acetate
(PMA)-differentiated U 937 cells were ex-
posed to the indicated concentrations of
TGF-1 for 18 hours. (B) PMA-differentiated
U 937 cells were exposed to 10 ng/mL TGF-1
for the indicated periods. (C) Human mono-
cytes were exposed to the indicated concentra-
tions of TGF-1 for 18 hours. Thereafter, the
whole cell binding assay was performed with
32 nmol/L [3H] dexamethasone. Values are
mean  SD of triplicate determinations.
luciferase reporter gene [15] was transiently transfected
into PMA-differentiated U 937 cells. In multiple trans-
fection experiments, the relative expression of luciferase
using ph GR Luc was about five-to tenfold greater than
the background measured with the promoterless vector.
Cell exposure to 10 ng/mL TGF-1 for 18 hours did not
increase this expression (6.7  2.0 vs. 7.1-  2.0-fold
induction, NS, N  3). Thus, the –2738 to 19 fragment
of the human GR promoter is conceivably not involved
in the control of GR gene transcription by TGF-1.Fig. 2. Effect of transforming growth factor-1 (TGF-1) on the num-
ber and the affinity of [3H] dexamethasone binding sites. Saturation
binding (A) and Scatchard analysis of [3H] dexamethasone binding data Both Smads and AP-1 mediate TGF-1 stimulation of
(B) obtained from untreated cells () and cells exposed to 10 ng/mL
GR gene transcriptionTGF-1 for 18 h (). One representative experiment out of three is
shown. Smad proteins play an essential role in TGF-1–
mediated signal transduction and gene expression. To
investigate whether Smad 2 and/or Smad 3 were involvedand TGF-1–treated cells. This result indicated that a
in TGF-1 signaling for GR expression, transient over-posttranscriptional mechanism was not involved in the
expression studies were performed using dominant-nega-accumulation of GR mRNA. Therefore, to further con-
tive mutant forms of Smad 2 and Smad 3, Smad 2
c,firm the role of a transcriptional mechanism in the re-
and Smad 3
c, respectively. These constructs lack thesponse to TGF-1, [3H] dexamethasone specific binding
C-terminal domain of the molecule and thus the phos-was analyzed in DRB-pretreated cells (Fig. 4B). This
phorylation and activation site [16]. As shown in Figuredrug did not affect [3H] dexamethasone specific binding
5, either construct antagonized the stimulatory effect ofunder control conditions but decreased by 60% the re-
TGF-1 on [3H] dexamethasone specific binding.sponse to TGF-1.
In addition to Smad, several transcription factors haveThe functional role of the 5 flanking region of the
been identified, which may mediate TGF-1 stimulationGR gene in the regulation of GR gene transcription by
of gene transcription. They include mainly Sp1 and AP-1TGF-1 was assessed by using a transient transfection
[20]. The possible involvement of Sp1 was analyzed usingassay. The ph GR Luc construct containing the 	2738
to 19 human GR promoter fragment upstream of the mithramycin, a drug that binds to the GC box and pre-
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Fig. 3. Effect of transforming growth factor-1
(TGF-1) on glucocorticoid receptor (GR)
expression. (A) Western blot analysis of the
dose-dependent effect of TGF-1 on GR pro-
tein level. Phorbol 12-myristate 13-acetate
(PMA)-differentiated U 937 cells were ex-
posed to the indicated concentrations of
TGF-1 for 18 hours. One representative ex-
periment out of three is shown. (B) Analysis
by Rnase protection assay (RPA) of the dose-
dependent effect of TGF-1 on the expression
of GR mRNA. PMA-differentiated U 937
cells were exposed to the indicated concentra-
tions of TGF-1 for 18 hours. Thereafter, total
RNA was harvested and subjected to RPA
with the indicated riboprobes. Values are
mean SD of data obtained in three indepen-
dent experiments. (C) One representative
RPA experiment is shown.
Fig. 4. Effect of transforming growth factor-1
(TGF-1) on glucocorticoid receptor (GR)
mRNA stability and GR gene transcription.
(A) Phorbol 12-myristate 13-acetate (PMA)-
differentiated U 937 cells were pretreated for
18 hours with () or without (O) TGF-1 (10
ng/mL). Thereafter, these cells were cultured for
0.5 to 8 hours in fresh media containing dichlo-
ro-l--d-ribofuranosylbenzimidasole(DRB)(50
mol/L), and harvested at the end of the indi-
cated periods. The levels of GR mRNA were
analyzed by Rnase protection assay (RPA) and
expressed as GR mRNA/cyclophilin mRNA
ratio. Values are mean SD of data obtained
in three separate experiments. (B) PMA-dif-
ferentiated U 937 cells were pretreated with
or without DRB (50 mol/L) for 10 minutes
and subsequently treated with () without
() TGF-1 (10 ng/mL) for 18 hours. Thereaf-
ter, the whole cell binding assay was per-
formed with 32 nmol/L [3H] dexamethasone.
Values are mean SD of quadruplicate deter-
minations.
vents Sp1 binding [21]. TGF-1 treatment stimulated 6A). The AP-1 DNA binding activity was transiently
increased after 3 hours and returned to a background[3H] dexamethasone specific binding to PMA-differenti-
ated U 937 cells approximately equally in the presence level 6 hours after the addition of 10 ng/mL TGF-1 to
the culture medium of PMA-differentiated U 937 cells.or absence of 10 nmol/L mithramycin (120.0  34.7 and
120.8  7.2 fmol [3H] dexamethasone bound per well, Second, cell transfection with AP-1 decoy oligodeoxy-
nucleotides resulted in clear attenuation of TGF-1 re-respectively; N  3), suggesting that Sp1 did not play a
critical role. In contrast, the role of AP-1 in TGF-1 sponse while transfection with mismatched decoy oligo-
deoxynucleotides did not (Fig. 6B). Together, theseresponse was demonstrated using two approaches. First,
an EMSA was performed using an oligodeoxynucleotide results indicate that both Smads and AP-1 are involved
in the induction of GR by TGF-1.probe containing the consensus AP-1 binding site (Fig.
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Fig. 5. Smad 2 and Smad 3 are required for
transforming growth factor-1 (TGF-1) stim-
ulation of glucocorticoid receptor (GR) gene
transcription. U 937 cells were transiently trans-
fected with empty vector, or dominant-nega-
tive mutant forms of Smad 2 (Smad 2
c) and
Smad 3 (Smad 3
c), differentiated with phor-
bol 12-myristate 13-acetate (PMA), and subse-
quently treated with or without TGF-1 (10
ng/mL) for 18 hours. The whole cell binding
assay was performed with 32 nmol/L [3H] dexa-
methasone. Values are mean  SD of data
obtained in five independent experiments.
*P  0.05 vs. control.
Fig. 6. Activator protein-1 (AP-1) is required
for transforming growth factor-1 (TGF-1)
stimulation of glucocorticoid receptor (GR) gene
transcription. (A) Phorbol 12-myristate 13-ace-
tate (PMA)-differentiated U 937 cells were pre-
treated with or without TGF-1 (10 ng/mL) for
the indicated periods. Nuclear extracts from
these cells were then analyzed for AP-1 DNA
binding activity by electrophoretic mobility
shift assay (EMSA). Data are representative
of two individual experiments. (B) U 937 cells
were transfected with AP-1 decoy oligodeoxy-
nucleotides (AP) or with mismatched decoy
oligodeoxynucleotides (MIS), differentiated
with PMA, and treated with or without TGF-1
(10 ng/mL) for 18 hours. Thereafter, the whole
cell binding assay was performed with 32 nmol/L
[3H] dexamethasone. Values are mean  SD
of data obtained in three independent experi-
ments. * P  0.05 vs control.
TGF-1 increases glucocorticoid signaling in TGF-1 increases glucocorticoid-induced inhibition of
IL-8 production by PMA-differentiated U 937 cellsPMA-differentiated U 937 cells
We assessed whether the changes in glucocorticoid We evaluated the pathophysiologic relevance of the
binding observed after TGF-1 treatment were associ- TGF-1–induced changes in glucocorticoid binding and
ated with changes in glucocorticoid signaling. Given that signaling. Given that monocyte production of IL-8 is
glucocorticoids regulate gene transcription in part via limited by glucocorticoids and not modified by TGF-1
the binding of GR to GRE [3], we used reporter genes [22], its determination was convenient to analyze the
under the control of promoters including several copies effects of TGF-1 on glucocorticoid response. Exposure
of the GRE. PMA-differentiated U 937 cells were tran- of U 937 cells to dexamethasone resulted in a dose-
siently transfected with MMTV-Luc construct containing dependent decrease in IL-8 production (Fig. 8). These
four GRE sites [17]. Exposure of these cells to dexameth- changes were significantly enhanced by cell preexposure
asone for 5 hours resulted in a dose-dependent increase to TGF-1 (P  0.01).
in luciferase activity (Fig. 7A). This response was en-
hanced by cell preexposure to 10 ng/mL TGF-1. As
DISCUSSIONshown in Figure 7B, the ability of TGF-1 to increase
Circulating glucocorticoids and locally producedglucocorticoid signaling appeared dose dependent.
TGF-1 play a major role in limiting and/or terminatingWe also tested the transactivation potential of GR
inflammatory processes. In that control, glucocorticoidsusing a simpler system, [GRE]2 TK Luc (i.e., a reporter
and TGF-1 do not act independently of each other butplasmid under the control of a minimal promoter, includ-
modulate each other’s activities. In particular, experi-ing two copies of the GRE). Exposure of U 937 cells
mental evidence suggests that glucocorticoids inducetransiently transfected with [GRE]2 TK Luc to dexa-
both the expression and the activation of TGF-. Dexa-methasone for 5 hours resulted in a dose-dependent in-
methasone up-regulates TGF- mRNA expression increase in luciferase activity (Fig. 7C). Again, this re-
human T lymphocytes [23] and macrophages [24], mainlysponse was enhanced by cell preexposure to 10 ng/mL
TGF-1. at a transcriptional level. Dexamethasone also promotes
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Fig. 7. Effects of transforming growth factor-1
(TGF-1) on glucocorticoid signaling. (A) U 937
cells were transiently transfected with the re-
porter plasmid MMTV-Luc, differentiated
with phorbol 12-myristate 13-acetate (PMA),
and treated with () or without (O) TGF-1
(10 ng/mL) for 18 hours. Thereafter, they were
exposed to the indicated concentrations of
dexamethasone for 5 hours, before luciferase
levels were measured. Values are mean  SD
of triplicate determinations. (B) U 937 cells
were transiently transfected with the reporter
plasmid MMTV-Luc, differentiated with PMA,
and treated with the indicated concentrations
of TGF-1 for 18 hours. Thereafter, they were
exposed to dexamethasone (10 nmol/L) for 5
hours, before luciferase levels were measured.
Values are mean of duplicate determinations
in one representative experiment out of 2. (C)
U 937 cells were transiently transfected with
the reporter plasmid [GRE]2 TK Luc, and ex-
periments were performed as indicated in (A).
Values are mean SD of quadruplicate deter-
minations.
U 937 cells up to a concentration of 10 ng/mL [27].
Scatchard analysis of the data indicated that TGF-1
increased the number of specific binding sites for [3H]
dexamethasone while the GR binding affinity for the
ligand was not significantly affected. Other anti-inflam-
matory mediators have been shown previously to affect
either constant. Both IL-4 and IL-13 increase GR num-
ber and decrease the affinity of these receptors for the
ligand [5, 28], while IL-10 and somatostatin only increase
GR number [6, 7].
Fig. 8. Effects of transforming growth factor1 (TGF-1) on glucocor- In the present study, the increase in GR number oc-
ticoid-induced inhibition of interleukin-8 (IL-8) production. Phorbol
curred after cell exposure to TGF-1 for several hours,12-myristate 13-acetate (PMA)-differentiated U 937 cells were pre-
treated for 18 hours with the indicated concentrations of TGF-1. suggesting the involvement of a de novo GR synthesis.
Thereafter, these cells were cultured for 24 hours in fresh media supple- Consistent with this hypothesis, we have shown that
mented or not with 1 (), 5 (), or 10 () nmol/L dexamethasone.
TGF-1 increased the expression of GR, and, for theIL-8 concentrations were measured in the supernatants by enzyme-
linked immunosorbent assay (ELISA). Values are mean  SD of tripli- same range of concentrations, the steady-state level of
cate determinations. GR mRNA. The underlying mechanisms could be tran-
scriptional and/or posttranscriptional. Posttranscriptional
mechanisms imply changes in the stability of GR mRNAthe activation of latent TGF- by inducing the secretion
that comprises a destabilizing adenine and uracil (AU)-of lysosomal proteases that are responsible for the cleav-
rich sequence in its 3 untranslated region [29]. In theage of the latency-associated peptide [25]. In turn, TGF-
present study, the half-life of the GR mRNA was shortpotentiates the inhibitory role of dexamethasone on the
(3 hours), as previously reported [29], and remainedgrowth of monocytic cells [26]. In the present study we
unmodified after cell exposure to TGF-1, thus rulinghave extended these findings by demonstrating that
out a role for posttranscriptional mechanisms. In furtherTGF-1 enhances glucocorticoid binding and thereby
experiments, we demonstrated both the importance ofpotentiates glucocorticoid responsiveness. Exposure of
transcriptional mechanisms and the involvement of AP-1PMA-differentiated cells or human monocytes to recom-
and Smad 2/3. These transcription factors have beenbinant TGF-1 for 18 hours increased [3H] dexametha-
shown to participate in TGF-1 signaling [11] and tosone specific binding to these cells. The response was
cooperate to mediate TGF-1–induced gene expressionnot related to an increase in cell number or viability, as
[30, 31]. The promoter of human GR gene contains con-estimated by trypan blue exclusion (data not shown).
sensus binding site for AP-1, which is located at 	899This is in agreement with previous studies showing that
TGF-1 does not affect the proliferation or viability of to 	893 [32]. As AP-1 is very potent in stimulating GR
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gene transcription [15], this AP-1 site might play a critical CONCLUSION
role in GR gene regulation by TGF-1. However, Our results provide insights into the cross-regulation
TGF-1 did not increase the expression of a reporter between GR and TGF-1 signaling pathways. In addi-
gene driven by the –2738 to 19 fragment of the human tion, they suggest that TGF-1 may exert anti-inflamma-
GR promoter. Thus, AP-1 might bind specific response tory activities in part by increasing the binding of gluco-
element(s) located upstream from this region. In support corticoids to GR. Its importance in the development of
of this hypothesis, computer analysis has identified a puta- inflammatory reaction in vivo awaits further investiga-
tive AP-1 site at 	3922 to 	3914 (TTGACTCAA). tion.
Smad 2/3 might also participate in the control of GR
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